Lakefront Biotherapeutics | GLPG - Trade Creditors


Lakefront Biotherapeutics reported EUR66.35M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
argenx SE USD 719M 164.73M Jun/2026
AstraZeneca USD 23.57B 679M Sep/2026
Biogen USD 430.3M 26.4M Sep/2026
Genmab DKK 116M 110M Jun/2026
Gilead Sciences USD 934M 260M Sep/2026
GlaxoSmithKline GBP 15.63B 1.29B Sep/2026
GRIFOLS EUR 1B 160M Jun/2026
Hikma Pharmaceutical USD 715M 104M Dec/2025
Incyte USD 235.37M 1.16B Sep/2026
Merck EUR 2.07B 61M Jun/2026
Neurocrine Biosciences USD 754.1M 612.1M Sep/2026
Novartis USD 4.24B 15M Sep/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sanofi EUR 24.55B 957M Sep/2026
UCB EUR 4.04B 755M Dec/2025
Vertex Pharmaceuticals USD 3.71B 99.2M Sep/2026